Concepedia

Michaele Roemmele

MR

Statistics

Publications

1

Citations

271

H-Index

1

Active since

2017

Affiliations

Roche (Netherlands)(Current)

Michaele Roemmele is an author at Roche (Netherlands).

Publications per year

2017–2017

1

Publications

1

Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines

Christian Klein, Inja Waldhauer, Valeria Nicolini et al. · OncoImmunology · 2017 · 271 citations · Full text

1–1 of 1